Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report)
Kazunari Tateishi,Hidenori Mizugaki,Yasuyuki Ikezawa,Ryo Morita,Keiki Yokoo,Toshiyuki Sumi,Hajime Kikuchi,Yasuo Kitamura,Atsushi Nakamura,Maki Kobayashi,Mari Aso,Nozomu Kimura,Fumiaki Yoshiike,Megumi Furuta,Hisashi Tanaka,Motoki Sekikawa,Tsutomu Hashiya,Yuka Fujita,Satoshi Oizumi ANNALS OF ONCOLOGY（2023）
AI 理解论文
溯源树
样例
